Pharmacodynamic EffIcacy and Clinical Benefit of AT 007 in Patients With Sorbitol Dehydrogenase (SORD) Deficiency

NCT05397665 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Hereditary Neuropathy Caused by SORD Deficiency

Interventions

DRUG: AT-007
DRUG: Placebo

Sponsor

Applied Therapeutics, Inc.